Skip to main content

News | Australia: Scientists begin tests on two possible vaccines

5-6 minutes - BBC

CSIRO scientists at work in the lab testing the virus vaccines Image copyright CSIRO
Image caption CSIRO scientists are testing two vaccine options
Scientists in Australia have begun testing two potential coronavirus vaccines in "milestone" lab trials.
The vaccines, made by Oxford University and US company Inovio Pharmaceutical, have been cleared for animal testing by the World Health Organization.
Australia's national science agency will assess if the vaccines work, and if they would be safe for humans.
The first human trial took place in the US last month, but skipped a stage of animal testing.
There are several other vaccine developments occurring around the world at the moment at extraordinary speed.
But Australia's Commonwealth Scientific and Industrial Research Organisation (CSIRO) says its tests will be the first comprehensive pre-clinical trials of the vaccines to use an animal model.
Researchers said the speed and level of global co-operation that led to this stage had been unprecedented.
"Normally it takes about one-to-two years to get to this point and we've in fact shortened that to a period of a couple of months," Dr Rob Grenfell from the CSIRO told reporters on Thursday.

How will it work?

In the past few days, the CSIRO team has inserted vaccine samples into ferrets - small, furry mammals which have been proven to contract the coronavirus in the same way humans do.
Sars-CoV-2 is the virus which causes the disease Covid-19. There are at least 20 vaccines in development around the world.
The CSIRO is testing two options selected by a global consortium overseeing most of this research, the Coalition for Epidemic Preparedness Innovations.
One option, developed by the University of Oxford, is a vector vaccine. It uses a "defective" virus to introduce the proteins of the coronavirus to the immune system and induce a response.
"But they're not able to replicate... so there's no possibility of becoming ill through this particular vaccine," said Prof Trevor Drew, director of the Australian Animal Health Laboratory in Victoria, where the testing is being carried out.

He described the other vaccine - from Inovio - as "rather different but nonetheless exciting".
It is designed to encode certain proteins of the coronavirus to the immune system, prompting the body's cells to generate those proteins before the immune system reacts to them.
"It's very important to take a multi-pronged approach to this," said Prof Drew. "It gives us the best chance of success."

How soon could we get results?

The first results from the animal tests could be revealed as early as June, the scientists said.
If successful, the vaccines could then be moved into clinical trials that could be conducted at labs elsewhere.

Media playback is unsupported on your device
Media captionCoronavirus: Researchers at Cambridge race for a vaccine
At that point, the race to get the medicine into the general market could be accelerated, but experts warn it would still involve a minimum 18-month timeline to meet regulatory tests and standards.
The Oxford University vaccine, for example, is also being tested by another lab on a separate animal to comply with US regulations.
"All of the [vaccine] candidates actually have a multitude of other companies and organisations involved because no single organisation can actually produce a vaccine," said Dr Grenfell.
But he said he was "optimistic" about the work, given the level of global collaboration.
"This is a true collaboration across academic, public, and also private sectors to in fact actually achieve success at this point," he said.
Reporting by the BBC's Frances Mao


Popular posts from this blog

Analysis | The Cybersecurity 202: How the shutdown could make it harder for the government to retain cybersecurity talent

By Joseph Marks 13-17 minutes THE KEY President Trump delivers an address about border security amid a partial government shutdown on Jan. 8. (Carolyn Kaster/AP) The partial government shutdown that's now in its 18th day is putting key cyber policy priorities on hold and leaving vital operations to a bare bones staff. But the far greater long-term danger may be the blow to government cyber defenders' morale, former officials warn. With the prospect of better pay and greater job security in the private sector, more government cyber operators are likely to decamp to industry, those former officials tell me, and the smartest cybersecurity graduates will look to industry rather than government to hone their skills. That’s especially dangerous, they say, considering the government’s struggle to recruit and retain skilled workers amid a nationwide shortage of cybersecurity talent. About 20 percent of staffers are furloughed at the De

Democrats call for investigation into Trump’s iPhone use after a report that China is listening:Analysis | The Daily 202 I The Washington Post. By James Hohmann _________________________________________________________________________________ President Trump and Chinese President Xi Jinping visit the Great Hall of the People in Beijing last November. (Andrew Harnik/AP) With Breanne Deppisch and Joanie Greve THE BIG IDEA: If Democrats win the House in two weeks, it’s a safe bet that one of the oversight hearings they schedule for early next year would focus on President Trump’s use of unsecured cellphones. The matter would not likely be pursued with anywhere near the gusto that congressional Republicans investigated Hillary Clinton’s use of a private email server during her time as secretary of state. Leaders of the minority party have higher priorities . But Democratic lawmakers made clear Thursday morning that they will not ignore a New York Times report that Trump has refused to stop using iPhones in the White House, despite repeated warnings from U.S. intelligence offici

RTTNews: Morning Market Briefing.-Weekly Jobless Claims Edge Down To 444,000. May 13th 2010

Morning Market Briefing Thu May 13 09:01 2010   Commentary May 13, 2010 Stocks Poised For Lackluster Open Amid Mixed Market Sentiment - U.S. Commentary Stocks are on pace for a mixed start to Thursday's session, as a mostly upbeat jobs report continued to relieve the markets while some consternation regarding the European debt crisis remained on traders' minds. The major index futures are little changed, with the Dow futures down by 4 points. Full Article Economic News May 13, 2010 Weekly Jobless Claims Edge Down To 444,000 First-time claims for unemployment benefits showed another modest decrease in the week ended May 8th, according to a report released by the Labor Department on Thursday, although the number of claims exceeded estimates due to an upward revision to the previous week's data. Full Article May 13, 2010 Malaysia's Decade High Growth Triggers Policy Tightening Malaysia's economy grew at the fastest pace in a decade in